However, the results of KD are still discordant, as follows: in a 2016 study using KD in mice with glioma, it was observed that rat gliomas are able to oxidize ketone bodies and overexpress monocarboxylate transporter 1 (MCT1) when nourished with a ketogenic diet. The gene discussed is SLC16A1; the disease is central nervous system cancer.